APA

Richie T. L., Charoenvit Y., Wang R., Epstein J. E., Hedstrom R. C., Kumar S., Luke T. C., Freilich D. A., Aguiar J. C., Sacci J. B., Sedegah M., Nosek R. A., De La Vega P., Berzins M. P., Majam V. F., Abot E. N., Ganeshan H., Richie N. O., Banania J. G., Baraceros M. F. B., Geter T. G., Mere R., Bebris L., Limbach K., Hickey B. W., Lanar D. E., Ng J., Shi M., Hobart P. M., Norman J. A., Soisson L. A., Hollingdale M. R., Rogers W. O., Doolan D. L. & Hoffman S. L. (20130910). Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA. : Human vaccines & immunotherapeutics.

Chicago

Richie Thomas L, Charoenvit Yupin, Wang Ruobing, Epstein Judith E, Hedstrom Richard C, Kumar Sanjai, Luke Thomas C, Freilich Daniel A, Aguiar Joao C, Sacci John B, Sedegah Martha, Nosek Ronald A, De La Vega Patricia, Berzins Mara P, Majam Victoria F, Abot Esteban N, Ganeshan Harini, Richie Nancy O, Banania Jo Glenna, Baraceros Maria Fe B, Geter Tanya G, Mere Robin, Bebris Lolita, Limbach Keith, Hickey Bradley W, Lanar David E, Ng Jennifer, Shi Meng, Hobart Peter M, Norman Jon A, Soisson Lorraine A, Hollingdale Michael R, Rogers William O, Doolan Denise L and Hoffman Stephen L. 20130910. Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA. : Human vaccines & immunotherapeutics.

Harvard

Richie T. L., Charoenvit Y., Wang R., Epstein J. E., Hedstrom R. C., Kumar S., Luke T. C., Freilich D. A., Aguiar J. C., Sacci J. B., Sedegah M., Nosek R. A., De La Vega P., Berzins M. P., Majam V. F., Abot E. N., Ganeshan H., Richie N. O., Banania J. G., Baraceros M. F. B., Geter T. G., Mere R., Bebris L., Limbach K., Hickey B. W., Lanar D. E., Ng J., Shi M., Hobart P. M., Norman J. A., Soisson L. A., Hollingdale M. R., Rogers W. O., Doolan D. L. and Hoffman S. L. (20130910). Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA. : Human vaccines & immunotherapeutics.

MLA

Richie Thomas L, Charoenvit Yupin, Wang Ruobing, Epstein Judith E, Hedstrom Richard C, Kumar Sanjai, Luke Thomas C, Freilich Daniel A, Aguiar Joao C, Sacci John B, Sedegah Martha, Nosek Ronald A, De La Vega Patricia, Berzins Mara P, Majam Victoria F, Abot Esteban N, Ganeshan Harini, Richie Nancy O, Banania Jo Glenna, Baraceros Maria Fe B, Geter Tanya G, Mere Robin, Bebris Lolita, Limbach Keith, Hickey Bradley W, Lanar David E, Ng Jennifer, Shi Meng, Hobart Peter M, Norman Jon A, Soisson Lorraine A, Hollingdale Michael R, Rogers William O, Doolan Denise L and Hoffman Stephen L. Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA. : Human vaccines & immunotherapeutics. 20130910.